新产品上线! Email验证工具 - 限时免费试用中立即试用

外贸营销群发邮件之前,先批量验证邮箱地址是否有效,可节省成本,提高发送成功率,减少被列入黑名单风险。 更多需求:邮箱采集/邮件群发

人工筛选的结果如何传达给注册人?如果没有采取任何行动,注册人是否会收到通知?成员国如何决定后续行动?

问题(中文)
人工筛选的结果如何传达给注册人?如果没有采取任何行动,注册人是否会收到通知?成员国如何决定后续行动?
Question (EN)
How is the outcome of the manual screening communicated to registrants? Will the registrant be informed if there is no action? How do Member States decide on the follow up actions?
中文内容由 Google Cloud Translation 自动生成,仅供参考;请以英文原文为准。问答资料来自欧盟化学品管理局(ECHA)官方网站。
答案(中文)
我们建议您定期关注 ECHA 的发布情况,了解您的物质是否已开始采取进一步行动:http://echa.europa.eu/information-on-chemicals 手动筛选的结果可能如下: 合规性检查候选物质(CCH):未满足标准信息要求:如果结果为 CCH,且该物质被 ECHA 视为优先事项,则该物质将出现在可能受 CCH 约束的物质清单中:http://echa.europa.eu/regulations/reach/evaluation/compliance-checks 物质评估候选物质(CoRAP 物质):每年 10 月,CoRAP 草案都会在 ECHA 网站上发布:http://echa.europa.eu/information-on-chemicals/evaluation/community-rolling-action-plan。如果手动筛选的结果为物质评估候选物质,则该物质将出现在 CoRAP 草案中。进一步监管风险管理的候选对象:风险管理选项分析 (RMOA):如果手动筛选的结果为 RMOA,则该物质将出现在公共活动协调工具 (PACT) 上,网址为:http://echa.europa.eu/pact 欧盟层面的协调分类和标签 (CLH) 提案:如果结果是 CLH 提案,则一旦成员国准备好准备档案,将在以下网址提供这样做的意向:http://echa.europa.eu/registry-current-classification-and-labelling-intentions 在确认 SVHC 属性并决定进一步的监管风险管理之前是否需要进一步评估(例如,该物质需要由 PBT 或 ED 专家组进一步评估和讨论):如果结果是进一步评估,并且需要调查 PBT/ED 属性,则此信息将在以下网址提供:http://echa.europa.eu/pact 需要采取其他行动(例如,根据其他法规执行或采取行动);无需采取进一步行动。如果手动筛选的结果是无需采取行动,则该物质将不会出现在任何后续行动中。但是,此信息不会公开,也不会传达给注册人。手动筛选并非完全全面,即使MSCA认为目前无需采取行动,该物质也可能会在以后再次被选中进行手动筛选。新信息或新用途可能会改变筛选结果。请注意,手动筛选的结果由成员国决定。一般而言,如果有足够的信息得出存在问题的结论,则立即采取的后续行动将是RMOA或CLH。如果需要首先获取更多信息,则成员国将选择合规性检查或物质评估。注册人可以通过及时更新其档案,提供任何补充信息/说明来影响手动筛选的结果。
Answer (EN)
We recommend monitoring the ECHA dissemination on a regular basis to see if some further actions have been started on your substance: http://echa.europa.eu/information-on-chemicals The manual screening can result in the following outcome options: Candidate for compliance check (CCH): standard information requirements are not fulfilled: if the outcome is CCH and the substance is considered a priority for ECHA, then the substance would appear in the list of substances potentially subject to CCH: http://echa.europa.eu/regulations/reach/evaluation/compliance-checks Candidate for substance evaluation (CoRAP substance): in October each year, the draft CoRAP is published on ECHA’s website: http://echa.europa.eu/ information-on-chemicals/evaluation/community-rolling-action-plan. If the outcome of the manual screening is as a candidate for substance evaluation, then the substance would appear in the draft CoRAP. Candidate for further regulatory risk management: Risk management option analysis (RMOA): if the outcome of the manual screening is RMOA, then the substance will appear on the Public Activities Coordination Tool (PACT) available at: http://echa.europa.eu/pact Proposal for harmonised classification and labelling (CLH) at EU level: if the outcome is a CLH proposal, then once the Member States are ready to prepare the dossier, the intention to do so will be available at: http://echa.europa.eu/registry-current-classification-and-labelling-intentions Need for further assessment before the SVHC properties are confirmed and further regulatory risk management can be decided (e.g. the substance needs to be further assessed and discussed by the PBT or ED expert groups): if the outcome is further assessment and the need is to investigate PBT/ED properties, then this information will be available on: http://echa.europa.eu/pact Need for other action (e.g. enforcement or action under other regulations); No need for further action. If the outcome of the manual screening would be no action, the substance would not appear in any follow up action. However, this information is not made publicly available and is not communicated to registrants. Manual screening cannot be completely comprehensive and even though the MSCA considers that no action is needed at present, the substance may be selected for manual screening again at a later date. New information or new uses may change the outcome of the screening.   Please note that it is up to the Member States to decide on the outcome of the manual screening. In general if there is enough information to conclude that there is a concern, then the immediate follow up would be RMOA or CLH. If there is a need first to generate additional information, then either compliance check or substance evaluation would be selected by Member States. Registrants can influence the outcome of manual screening by timely updating their dossiers with any additional information/clarification